Viking Therapeutics, Inc. (VKTX)
NASDAQ: VKTX · Real-Time Price · USD
32.39
-0.60 (-1.82%)
At close: Apr 28, 2026, 4:00 PM EDT
32.60
+0.21 (0.65%)
After-hours: Apr 28, 2026, 7:59 PM EDT

Viking Therapeutics Statistics

Total Valuation

VKTX has a market cap or net worth of $3.75 billion. The enterprise value is $3.05 billion.

Market Cap 3.75B
Enterprise Value 3.05B

Important Dates

The next confirmed earnings date is Wednesday, April 29, 2026, after market close.

Earnings Date Apr 29, 2026
Ex-Dividend Date n/a

Share Statistics

VKTX has 115.89 million shares outstanding. The number of shares has increased by 3.33% in one year.

Current Share Class 115.89M
Shares Outstanding 115.89M
Shares Change (YoY) +3.33%
Shares Change (QoQ) +1.50%
Owned by Insiders (%) 2.40%
Owned by Institutions (%) 62.74%
Float 113.07M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 5.82
P/TBV Ratio 5.87
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 9.33, with a Debt / Equity ratio of 0.00.

Current Ratio 9.33
Quick Ratio 9.21
Debt / Equity 0.00
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -7,023.96

Financial Efficiency

Return on equity (ROE) is -47.34% and return on invested capital (ROIC) is -32.33%.

Return on Equity (ROE) -47.34%
Return on Assets (ROA) -30.27%
Return on Invested Capital (ROIC) -32.33%
Return on Capital Employed (ROCE) -61.55%
Weighted Average Cost of Capital (WACC) 8.79%
Revenue Per Employee n/a
Profits Per Employee -$6.79M
Employee Count 53
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +29.61% in the last 52 weeks. The beta is 0.82, so VKTX's price volatility has been lower than the market average.

Beta (5Y) 0.82
52-Week Price Change +29.61%
50-Day Moving Average 33.52
200-Day Moving Average 32.77
Relative Strength Index (RSI) 42.92
Average Volume (20 Days) 2,114,356

Short Selling Information

The latest short interest is 23.11 million, so 19.94% of the outstanding shares have been sold short.

Short Interest 23.11M
Short Previous Month 24.01M
Short % of Shares Out 19.94%
Short % of Float 20.44%
Short Ratio (days to cover) 10.03

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -393.34M
Pretax Income -359.64M
Net Income -359.64M
EBITDA n/a
EBIT -393.34M
Earnings Per Share (EPS) -$3.19
Full Income Statement

Balance Sheet

The company has $705.74 million in cash and $137,000 in debt, giving a net cash position of $705.60 million or $6.09 per share.

Cash & Cash Equivalents 705.74M
Total Debt 137,000
Net Cash 705.60M
Net Cash Per Share $6.09
Equity (Book Value) 639.06M
Book Value Per Share 5.57
Working Capital 638.93M
Full Balance Sheet

Cash Flow

Operating Cash Flow -278.69M
Capital Expenditures n/a
Depreciation & Amortization 431,000
Net Borrowing n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

VKTX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -3.33%
Shareholder Yield -3.33%
Earnings Yield -9.58%
FCF Yield n/a

Analyst Forecast

The average price target for VKTX is $94.44, which is 191.57% higher than the current price. The consensus rating is "Strong Buy".

Price Target $94.44
Price Target Difference 191.57%
Analyst Consensus Strong Buy
Analyst Count 9
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1